NanoViricides, Inc.

Release Summary

Dr. Diwan presented data on the broad-spectrum anti-influenza drug candidates NV-INF-1 (injectable) and NV-INF-2 (oral) at the GTC Bio Influenza Conference on Friday.

NanoViricides, Inc.